Blocking the 3IL-17F-IL-17RA axis with anti-IL-17F antibodies in AD mice promoted the transition of microglia to the DAM/MGnD phenotype, improved microglial phagocytic function, and alleviated cognitive impairment [82]. Here, IL17F is linked to Alzheimer disease.